Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.
Condition(s) studied
Investigational drug(s) / intervention(s)
Exercise regime: Exercise
Study summary
The main objective of this project is to identify mechanisms for lung regeneration in patients with COPD induced by exercise training. The hypothesis is that adjusted exercise training improves disease outcome in these patients by decrease remodelling processes linked to oxidative stress, inflammatory and/or immunological pathways in the lung. Along the way, the investigator also expect to identify (or validate) biomarkers mirroring systemic processes such as reduced inflammation and ameliorating the epithelial barrier in these patients. These events may additionally act as potential targets for interventions.
Objectives (i) Evaluate biomarkers for regenerative processes, matrix turnover, stem cell activity and inflammatory patterns in lung tissue biopsies, blood- and urine samples correlated to vital lung parameters and physical capacity, before and after attending an exercise-training program.
(ii) Study the effects of exercise training on the pulmonary ventilation/perfusion ratio and quality of life.
(iii) Evaluate the relation between pathophysiology in the lung evaluated by CT scan, and systemic response measured by muscle biopsies and biomarkers in blood/urine.
(iv) Investigate in vitro cell behaviour and remodelling/regenerative processes altered in COPD patients upon exercise training (aim 1).
Eligibility
Primary outcome measure(s)
- Pulmonary Function — Baseline, post intervention at 12 wks
FEV1 (Forced Expiratory volume in one second)
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| Lund University | Lund | Sweden | Recruiting |
| Uppsala University | Uppsala | Sweden | Recruiting |
More Uppsala University trials in Sweden
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06335992 on ClinicalTrials.gov ↗ ← All trials in Sweden